互乐金-11促进肺腺癌瘤发生和免疫逃避

Cristina Cirauqui1,2,3, Laura Ojeda1,2, Itziar Otano1,2

  • 1H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12)/Spanish National Cancer Research Center (CNIO), Madrid, Spain.

概括

互乐金-11 (IL-11) 通过促进瘤细胞生长和创造免疫抑制微环境,驱动肺腺癌 (LUAD) 的进展. 针对IL-11/IL-11RA途径显示出显著的抗瘤效应,为LUAD患者提供了潜在的治疗策略.